ICH Q9 risk management applied to the compliance challenges between cGMP & safety design issues in manufacturing pharmaceutical & biotechnology facilities 3 Case Studies: High potent (HP1@5) plants, Bio-safety containmen
life cycle of a given pharmaceutical plant from its conceptual design (URS) until its operation. This new approach, thanks to the prior identification of critical parameters of pharmaceutical facilities, helps…

